Puma Biotechnology | PBYI - Market Capitalization


Puma Biotechnology reported $353.4M in Market Capitalization this June of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Agios Pharmaceuticals USD 2.01B 423M Mar/2026
Alnylam Pharmaceuticals USD 44.15B 8.39B Mar/2026
Amgen USD 189.89B 13.64B Mar/2026
Biogen USD 26.9B 1.09B Mar/2026
BioMarin Pharmaceutical USD 10.86B 553M Mar/2026
Esperion Therapeutics USD 885M 351M Dec/2025
Exelixis USD 10.89B 857M Mar/2026
Gilead Sciences USD 172.99B 20.71B Mar/2026
Incyte USD 18.73B 660M Mar/2026
Moderna USD 20.15B 8.53B Mar/2026
Novartis USD 307.76B 15.54B Mar/2026
Pfizer USD 153.81B 12.24B Mar/2026
PTC Therapeutics USD 5.64B 460M Mar/2026
Regeneron Pharmaceuticals USD 81.68B 560M Mar/2026
Roche Holding CHF 266.34B 55.46B Dec/2025
Sarepta Therapeutics USD 2.28B 30M Mar/2026
Takeda JPY 9.01T 1.37T Mar/2026
TG Therapeutics USD 5.31B 572M Mar/2026
Ultragenyx Pharmaceutical USD 2.06B 159M Mar/2026
Vanda Pharmaceuticals USD 279M 6M Dec/2024
Vertex Pharmaceuticals USD 113.58B 1.44B Mar/2026